首页> 外国专利> Method for determining the susceptibility getting an infection in nosocomial in a patient presenting a systemic inflammatory response associated or not have an infection.

Method for determining the susceptibility getting an infection in nosocomial in a patient presenting a systemic inflammatory response associated or not have an infection.

机译:确定表现出与感染相关或没有感染的全身性炎症反应的患者在医院感染的易感性的方法。

摘要

Determining susceptibility for contracting nosocomial infection in a patient having a systemic inflammatory response (non)associated with an infection, comprises collecting a biological sample from the patient and extracting biological material from biological sample; taking at least one specific reagent from an expression product of the target gene S100A9; and determining the expression of the target gene S100A9. Independent claims are included for: (1) establishing an early prognosis of survival in a patient having a systemic inflammatory response (non)associated with infection, or for determining the etiology of a systemic inflammatory response (non)associated with infection in patient, comprising (a) collecting biological sample from the patient and extracting from biological material from the biological sample, (b) collecting at least one reagent specific for an expression product of the target gene S100A9 and (c) determining the expression of the S100A9 target gene; (2) a first kit for determining susceptibility in contracting nosocomial infection in a patient having a systemic inflammatory response (non)associated with an infection comprising one reagent specific for S100A9 gene expression product; (3) use of at least one reagent for determining, in vitro, the susceptibility for contracting a nosocomial infection in a patient having systemic inflammatory response (non)associated with an infection; (4) a second kit for establishing an early prognosis for survival in a patient having a systemic inflammatory response (non)associated with an infection comprising at least one reagent specific for an expression product of S100A9 gene; and (5) use of at least one reagent for establishing, in vitro, a prognosis for survival in a patient having a systemic inflammatory response (non)associated with an infection.
机译:在患有与感染相关的全身性(非)炎症性反应的患者中确定感染医院感染的易感性,包括从患者收集生物样品并从生物样品中提取生物材料。从靶基因S100A9的表达产物中提取至少一种特异性试剂;确定靶基因S100A9的表达。包括以下独立权利要求:(1)在具有与感染相关的全身性炎症反应(非)的患者中确定生存的早期预后,或用于确定与感染相关的全身性炎症反应(非)的病因,包括: (a)从患者收集生物样品并从生物样品中提取生物材料,(b)收集至少一种对靶基因S100A9的表达产物具有特异性的试剂,以及(c)确定S100A9靶基因的表达; (2)第一种试剂盒,用于确定在患有(非)系统性炎症反应(非)并伴有感染的患者中感染医院感染的易感性,该试剂盒包含一种对S100A9基因表达产物具有特异性的试剂; (3)使用至少一种试剂在体外确定在具有与感染相关的全身性炎症反应(非)的患者中感染医院感染的敏感性; (4)第二种试剂盒,用于建立具有与感染相关的全身性炎性反应(非)的患者的存活的早期预后,所述试剂盒包含至少一种对S100A9基因的表达产物具有特异性的试剂; (5)使用至少一种试剂在体外建立具有与感染相关的全身性炎性反应(非)的患者的生存预后。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号